Beryl Drugs Ltd. Regularizes Appointment of Director and Approves Related Party Transactions

Beryl Drugs Ltd. held a board meeting on April 1, 2026, where several key decisions were made. The board considered and approved the date and notice for the Extra Ordinary General Meeting (EOGM) to regularize the appointment of Mr. Shailendra Pathak as the Whole Time Director and the appointment of Mrs. Neha Sarda as an Independent Director. The board also approved material related party transactions with M/s. Aminova Infusions P. Ltd., where Mr. Shailendra Pathak is a director holding 50% equity. The board took note of the cut-off date and remote e-voting period for the EOGM, and appointed Mrs. Dipika Kataria as the scrutinizer for the purpose of remote e-voting and voting at the EOGM. The board authorized directors to authenticate and file forms under the Companies Act, 2013 on behalf of the company. Abhay Bhandari & Associates, Chartered Accountants were appointed as the Internal Auditor for the financial year 2026-2027. The board also considered and approved any other resolutions with the permission of the chair.